1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY
Authors:
- J.M. LlovetJLJ.M. Llovet
- T. DecaensTDT. Decaens
- J.-L. RaoulJRJ.-L. Raoul
- E. BoucherEBE. Boucher
- M. KudoMKM. Kudo
- C. ChangCCC. Chang
- Y.-K. KangYKY.-K. Kang
- E. AssenatEAE. Assenat
- H.-Y. LimHLH.-Y. Lim
- V. BoigeVBV. Boige
- P. MathurinPMP. Mathurin
- L. FartouxLFL. Fartoux
- 1 April 2012
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 56, S549